Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPB - Cypress BioScience -- Ignore unavailable to you. Want to Upgrade?

To: muddphudd who wrote (233)	5/20/1998 5:07:00 PM
From: Jay Lowe	Respond to of 586

Cypress Bioscience Inc. 1Q1998 Financial Data Cypress Bioscience Inc. Condensed Financial Data (In thousands except per share data) (unaudited) Statements of Operations Quarter Ended March 31, 1998 1997 ---- ---- Total revenues $ 549 $ 848 Operating expenses 2,583 2,981 Interest income, net 101 94 Net loss $ (1,933) $ (2,039) Net loss per share $ (0.05) $ (0.06) Weighted average number of shares outstanding during the period 38,684 34,573 Balance Sheets March 31, Dec. 31, 1998 1997 ---- ---- Assets Cash and investments $ 7,356 $ 8,516 Other current assets 1,211 1,256 Non-current assets 1,899 2,017 Total assets $10,466 $11,789 Liabilities and Stockholders' Equity Current liabilities $ 1,922 $ 1,855 Long term liabilities 432 408 Stockholders' equity 8,112 9,526 Total liabilities and stockholders' equity $10,466 $11,789